Long-term clinical and real-world experience with Crohn’s disease treated with anti-tumor necrosis factor-α antibodies

BACKGROUND/AIMS: Although anti-tumor necrosis factor (TNF)-α agents are important therapeutic drugs for Crohn’s disease (CD), data regarding their long-term sustained effects are limited. Herein, we evaluated the long-term loss of response (LOR) to anti-TNF-α agents in patients with CD. METHODS: Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Otake, Haruka, Matsumoto, Satohiro, Mashima, Hirosato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association for the Study of Intestinal Diseases 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650333/
https://www.ncbi.nlm.nih.gov/pubmed/35350094
http://dx.doi.org/10.5217/ir.2021.00139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650333/
https://www.ncbi.nlm.nih.gov/pubmed/35350094
http://dx.doi.org/10.5217/ir.2021.00139

Ejemplares similares